Ellin Berman

7.6k total citations · 1 hit paper
99 papers, 3.8k citations indexed

About

Ellin Berman is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ellin Berman has authored 99 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Hematology, 40 papers in Genetics and 30 papers in Molecular Biology. Recurrent topics in Ellin Berman's work include Chronic Myeloid Leukemia Treatments (42 papers), Acute Myeloid Leukemia Research (36 papers) and Chronic Lymphocytic Leukemia Research (35 papers). Ellin Berman is often cited by papers focused on Chronic Myeloid Leukemia Treatments (42 papers), Acute Myeloid Leukemia Research (36 papers) and Chronic Lymphocytic Leukemia Research (35 papers). Ellin Berman collaborates with scholars based in United States, France and Italy. Ellin Berman's co-authors include Toby Gee, Glenn Heller, Mary L. McBride, Michael Andreeff, Raymond P. Warrell, Susan McKenzie, Sanford Kempin, Subhash C. Gulati, Jonathan E. Kolitz and David A. Scheinberg and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Ellin Berman

94 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts

2014 398 citations Aruna Kode, John S. Manavalan et al. Nature profile →

Peers

Countries citing papers authored by Ellin Berman

Since Specialization

Citations

This map shows the geographic impact of Ellin Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellin Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellin Berman more than expected).

Fields of papers citing papers by Ellin Berman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellin Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellin Berman. The network helps show where Ellin Berman may publish in the future.

Co-authorship network of co-authors of Ellin Berman

This figure shows the co-authorship network connecting the top 25 collaborators of Ellin Berman. A scholar is included among the top collaborators of Ellin Berman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellin Berman. Ellin Berman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia 2023 ·Current Hematologic Malignancy Reports ·Ellin Berman	5
2	Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity 2023 ·Clinical Journal of the American Society of Nephrology ·(unknown), (unknown), Victoria Gutgarts, Florin Marcel Musteata, Kinsuk Chauhan, (unknown), Kristin Meliambro, Steven Salvatore, (unknown), Marina Kremyanskaya, Bridget K. Marcellino, John Mascarenhas, Kirk N. Campbell, Lili Chan, Steven G. Coca, Ellin Berman, Edgar A. Jaimes, Evren U. Azeloglu	4
3	Disease characteristics and clinical outcomes in patients aged less than 40 with chronic lymphocytic leukemia 2018 ·Leukemia Research ·Bartlomiej Getta, Sean M. Devlin, Jae H. Park, Martin S. Tallman, Ellin Berman	2
4	Venetoclax Combined with Either a Hypomethylating Agent or Low-Dose Cytarabine Shows Activity in Relapsed and Refractory Myeloid Malignancies 2017 ·Blood ·Aaron D. Goldberg, Troy Z. Horvat, Meier Hsu, Sean M. Devlin, (unknown), (unknown), Amber C. King, Larry W. Buie, Jacob L. Glass, Michael J. Mauro, Eytan M. Stein, Ellin Berman, Virginia M. Klimek, Martin S. Tallman	18
5	FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice 2015 ·Leukemia ·Aruna Kode, Ioanna Mosialou, (unknown), Chozhavendan Rathinam, Rick A. Friedman, Julie Teruya‐Feldstein, Govind Bhagat, Ellin Berman, Stavroula Kousteni	73
6	Where Exactly Does Ponatinib Fit in Chronic Myelogenous Leukemia? 2014 ·Journal of the National Comprehensive Cancer Network ·Ellin Berman	0
7	Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts breakdown → 2014 ·Nature ·Aruna Kode, John S. Manavalan, Ioanna Mosialou, Govind Bhagat, Chozha Vendan Rathinam, Na Luo, Hossein Khiabanian, Albert Lee, Vundavalli V. Murty, Richard A. Friedman, Andrea M. Brum, David S. Park, Naomi Galili, Siddhartha Mukherjee, Julie Teruya‐Feldstein, Azra Raza, Raúl Rabadán, Ellin Berman, Stavroula Kousteni	398
8	Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors 2013 ·Leukemia Research ·Ellin Berman, Monica Girotra, (unknown), Suzanne Chanel, Robert G. Maki, (unknown), H. William Strausś, Martin Fleisher, Glenn Heller, Azeez Farooki	23
9	Chronic Myelogenous Leukemia 2012 ·Journal of the National Comprehensive Cancer Network ·Susan O’Brien, Camille N. Abboud, Mojtaba Akhtari, Jessica K. Altman, Ellin Berman, Daniel J. DeAngelo, Steven M. Devine, Amir T. Fathi, Jason Gotlib, Madan Jagasia, Joseph O. Moore, Javier Pinilla‐Ibarz, Jerald P. Radich, Vishnu Reddy, Neil P. Shah, Paul J. Shami, Benjamin D. Smith, David S. Snyder, Meir Wetzler, Furhan Yunus	20
10	Genetic mutations in chronic myelogenous leukemia 2012 ·Current Opinion in Hematology ·Ellin Berman	1
11	Omacetaxine: the FDA decision. 2011 ·PubMed ·Ellin Berman	6
12	Chronic Myelogenous Leukemia 2009 ·Journal of the National Comprehensive Cancer Network ·Susan O’Brien, Ellin Berman, Hossein Borghaei, Daniel J. DeAngelo, Marcel P. Devetten, Steven M. Devine, Harry P. Erba, Jason Gotlib, Madan Jagasia, Joseph O. Moore, Tariq I. Mughal, Javier Pinilla‐Ibarz, Jerald P. Radich, Neil P. Shah, Paul J. Shami, Benjamin D. Smith, David S. Snyder, Martin S. Tallman, Moshe Talpaz, Meir Wetzler	175
13	Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapy 2002 ·Cancer ·Ellin Berman, Claudia Little, Bonnie Teschendorf, (unknown), Glenn Heller	5
14	Recent advances in the treatment of acute leukemia 1997 ·Current Opinion in Hematology ·Ellin Berman	12
15	Long‐term follow‐up of three randomized trials comparing idarubicin and daunorubicin as induction therapies for patients with untreated acute myeloid leukemia 1997 ·Cancer ·Ellin Berman, Peter H. Wiernik, Ralph Vogler, (unknown), Alfred A. Bartolucci, Fredrick S. Whaley	1
16	Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone. 1996 ·Journal of Clinical Oncology ·(unknown), P. Maslak, E. Feldman, Ellin Berman, Joseph Bertino, Toby Gee, (unknown), Karen Seiter, David A. Scheinberg, David W. Golde	48
17	Reasons That Patients with Acute Myelogenous Leukemia Do Not Undergo Allogeneic Bone Marrow Transplantation 1992 ·New England Journal of Medicine ·Ellin Berman, Claudia Little, Toby Gee, Richard J. O’Reilly, Bayard D. Clarkson	37
18	Importance of Long-Term Follow-up in Evaluating Treatment Regimens for Adults with Acute Lymphoblastic Leukemia 1990 ·Hämatologie und Bluttransfusion ·B Clarkson, Jeffrey J. Gaynor, C. Little, Ellin Berman, Sanford Kempin, Michael Andreeff, Subhash C. Gulati, Isabel Cunningham, Toby Gee	20
19	A Cause-Specific Hazard Rate Analysis of Prognostic Factors Among 199 Adults With Acute Lymphoblastic Leukemia 1988 ·Journal of Clinical Oncology ·Jeffrey J. Gaynor, Douglass Chapman, Claudia Little, Susan McKenzie, (unknown), Michael Andreeff, Zalmen A. Arlin, Ellin Berman, Sanford Kempin, Toby Gee, Bayard Clarkson	1
20	A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. 1988 ·Journal of Clinical Oncology ·Jeffrey J. Gaynor, Douglass Chapman, C. Little, Susan McKenzie, Wilson H. Miller, Michael Andreeff, (unknown), Ellin Berman, Sanford Kempin, Toby Gee	138

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact